Equity Bancshares Details Lincoln Merger Economics: 5.1% EPS Accretion in 2027, 3.8% TBV Dilution
EQBK sits 32% above its 52-week low of $38.6.
Summary
Equity Bancshares provided detailed merger economics for its $123M Lincoln Bancorp acquisition, projecting 5.1% EPS accretion in 2027, 3.8% TBV dilution with 2.6-year earn-back, and 30% cost savings phased over three years.
Key Events · M&A and Partnerships · EQBK
-
Merger Economics Detailed
EPS accretion projected at 5.1% in 2027, 7.5% in 2028, and 10.1% in 2029, with tangible book value dilution of 3.8% and earn-back of ~2.6 years.
-
Cost Savings and Credit Marks
Cost savings modeled at 30% of Lincoln's noninterest expense phased 50%/75%/100% over 2027-2029; gross credit mark of $18M (1.5% of loans) and loan rate discount of $27.8M (2.3%).
-
Pro Forma Balance Sheet
Combined company modeled at ~$9.1B assets, $6.7B loans, $7.7B deposits after reducing ~$250-300M excess liquidity; CET1 ratio of 10.6% and TCE/TA of 8.6%.
-
Deal Structure and Timing
Lincoln shareholders receive ~1.89M Equity shares plus $29.5M cash for total ~$123M (1.05x tangible book value); closing expected Q4 2026 with system conversion Q2 2027.
Analysis · EQBK · Finance
This conference call transcript provides the first detailed financial modeling for the $123M Lincoln Bancorp acquisition announced yesterday. Management projects EPS accretion of 5.1% in 2027 rising to 10.1% by 2029, with tangible book value dilution of 3.8% and a 2.6-year earn-back. Cost savings of 30% of Lincoln's noninterest expense are phased in over three years. The deal adds $1.7B in assets and 16 Iowa branches, expanding Equity into Des Moines and Waterloo-Cedar Falls. Pro forma capital remains strong with CET1 at 10.6%. The transaction is expected to close in Q4 2026 with system conversion in Q2 2027.
How filings like this one have moved
In the 30 days to Sep 13, 2026, 35.3% of the 1324 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, EQBK was trading at $50.90 on NYSE in the Finance sector, with a market capitalization of approximately $1B. The 52-week trading range was $38.60 to $52.27. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.